Entyvio vedolizumab Shows Higher Rates of Mucosal Healing Versus TNFAntagonist Therapy in Ulcerative Colitis and Crohn's Disease Patients in Comparative Effectiveness RealWorld Data Analysis

OSAKA Japan February 17 2018 PRNewswire New clinical study also provides data for Entyvio® in inducing complete mucosal healing and endoscopic remission particularly in bionaïve patients Takeda Pharmaceutical Company Limited TSE 4502 &a...